Citi opens ‘positive catalyst watch’ on Genpact into earnings

Citi opened a “30-day positive catalyst watch” on shares of Genpact while keeping a Neutral rating on the name with a $35 price target. The firm expects Genpact to report a slight top-line beat in Q2, its Q3 revenue outlook to come in slightly higher than consensus expectations, and for its 2024 outlook to again be raised. Genpact has set relatively conservative expectations for 2024 and there could be a positive reaction on the perception of improved execution, the analyst tells investors in a research note.